Anna Fagotti
#163,160
Most Influential Person Now
Researcher
Anna Fagotti's AcademicInfluence.com Rankings
Anna Fagotticomputer-science Degrees
Computer Science
#9554
World Rank
#10029
Historical Rank
Machine Learning
#4212
World Rank
#4261
Historical Rank
Artificial Intelligence
#4562
World Rank
#4624
Historical Rank
Database
#6523
World Rank
#6758
Historical Rank
Download Badge
Computer Science
Anna Fagotti's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Anna Fagotti Influential?
(Suggest an Edit or Addition)Anna Fagotti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (2020) (559)
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. (2016) (271)
- A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study (2006) (255)
- Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). (2007) (245)
- Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. (2008) (244)
- GLUT‐1 expression in ovarian carcinoma (2001) (170)
- Laparoscopic colorectal resection for bowel endometriosis: feasibility, complications, and clinical outcome. (2009) (164)
- Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (LESS) for benign adnexal disease: a randomized trial. (2011) (160)
- Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. (2002) (157)
- A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. (2010) (146)
- p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. (2000) (145)
- COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers (2020) (144)
- Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) (2020) (138)
- Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. (2005) (133)
- Discoid or segmental rectosigmoid resection for deep infiltrating endometriosis: a case-control study. (2010) (128)
- SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer (2020) (123)
- A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer. (2013) (113)
- Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. (1995) (113)
- Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept. (2015) (102)
- Ecology: The proximate cause of frog declines? (2007) (102)
- Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. (2010) (102)
- First 100 early endometrial cancer cases treated with laparoendoscopic single-site surgery: a multicentric retrospective study. (2012) (100)
- Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up. (2012) (98)
- Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. (2011) (98)
- Terminologia Anatomica versus unofficial descriptions and nomenclature of the fasciae and ligaments of the female pelvis: a dissection-based comparative study. (2005) (97)
- Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. (2007) (97)
- Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. (2013) (96)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial (2009) (86)
- A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. (2004) (86)
- IMPACT OF INTERVAL DEBULKING SURGERY ON CLINICAL OUTCOME IN PRIMARY UNRESECTABLE FIGO STAGE IIIC OVARIAN CANCER PATIENTS (2003) (78)
- Laparoendoscopic single-site surgery (LESS) for ovarian cyst enucleation: report of first 3 cases. (2009) (77)
- Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer. (2011) (72)
- Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer. (2014) (71)
- A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy (2008) (70)
- Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature (2018) (68)
- Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer (2015) (67)
- Delaying surgery for patients with a previous SARS-CoV-2 infection (2020) (66)
- Morbidity After Pelvic Exenteration for Gynecological Malignancies: A Retrospective Multicentric Study of 230 Patients (2014) (66)
- Delaying surgery for patients with a previous SARS-CoV-2 infection (2020) (66)
- Total laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot study (2011) (66)
- The new robotic TELELAP ALF-X in gynecological surgery: single-center experience (2015) (65)
- Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. (2010) (64)
- Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (2016) (63)
- Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series. (2014) (62)
- Completion Surgery After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Comprehensive Analysis of Pattern of Postoperative Complications (2014) (62)
- HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome. (2011) (62)
- Minilaparoscopic versus single-port total hysterectomy: a randomized trial. (2013) (62)
- Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (2020) (61)
- Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. (2009) (61)
- Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study. (2016) (60)
- p21WAF1/CIP1 protein expression in primary ovarian cancer. (2000) (60)
- A prospective study of laparoscopy versus minilaparotomy in the treatment of uterine myomas. (2005) (59)
- Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes (2012) (59)
- The effects of copper on actin and fibronectin organization in Mytilus galloprovincialis haemocytes. (1996) (59)
- Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management. (2020) (57)
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. (2004) (56)
- BRCA mutational status, initial disease presentation, and clinical outcome in high‐grade serous advanced ovarian cancer: a multicenter study (2017) (56)
- Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors. (2013) (56)
- How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study (2020) (55)
- Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results. (2012) (55)
- Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. (2019) (55)
- Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy (2013) (53)
- Excisional cone as fertility-sparing treatment in early-stage cervical cancer. (2011) (53)
- Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? (2010) (52)
- p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer (1999) (51)
- Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study. (2014) (50)
- Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. (2015) (49)
- Evidence of Batrachochytrium dendrobatidis Infection in Water Frogs of the Rana esculenta Complex in Central Italy (2005) (49)
- Randomized study comparing use of THUNDERBEAT technology vs standard electrosurgery during laparoscopic radical hysterectomy and pelvic lymphadenectomy for gynecologic cancer. (2014) (48)
- Minilaparotomy in the management of benign gynecologic disease. (2005) (47)
- Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic (2020) (46)
- Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience. (2017) (46)
- Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations. (2020) (46)
- Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic (2020) (46)
- Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study. (2018) (45)
- Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment. (2002) (45)
- Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: a double-institution case-control study. (2013) (44)
- ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma (2021) (43)
- Ultrasound evaluation of intra‐abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study (2012) (43)
- The lymphatic drainage of the uterine cervix in adult fresh cadavers: anatomy and surgical implications. (2010) (42)
- Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back. (2017) (42)
- Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial (2020) (41)
- The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy (2019) (41)
- Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study. (2016) (41)
- Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. (2014) (41)
- Parasitism by Dermocystidium ranae in a population of Rana esculenta complex in Central Italy and description of Amphibiocystidium n. gen. (2003) (40)
- Sentinel-Node Biopsy in Early Stage Ovarian Cancer: Preliminary Results of a Prospective Multicentre Study (SELLY). (2019) (40)
- Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). (2016) (40)
- Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study. (2017) (40)
- BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study (2018) (40)
- Peritoneal carcinosis of ovarian origin. (2010) (39)
- Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. (2014) (39)
- Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience (2014) (39)
- Near-Infrared Imaging with Indocyanine Green for Detection of Endometriosis Lesions (Gre-Endo Trial): A Pilot Study. (2018) (38)
- Laparoendoscopic single‐site surgery for total hysterectomy (2010) (38)
- Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience (2014) (38)
- The Pathogen of Frogs Amphibiocystidium ranae Is a Member of the Order Dermocystida in the Class Mesomycetozoea (2005) (38)
- Robotic Single-Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta-analysis (2019) (38)
- Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial). (2018) (38)
- A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment. (2016) (38)
- Risk of Postoperative Pelvic Abscess in Major Gynecologic Oncology Surgery: One-Year Single-Institution Experience (2010) (37)
- Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer (2016) (37)
- Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study. (2016) (36)
- Systematic Pelvic and Aortic Lymphadenectomy in Advanced Ovarian Cancer Patients at the Time of Interval Debulking Surgery: A Double-Institution Case–Control Study (2012) (36)
- TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes. (2015) (35)
- Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study (2017) (34)
- Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis. (2014) (34)
- Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies. (2015) (34)
- Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. (1997) (34)
- Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival. (2016) (33)
- Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement (2019) (33)
- Neoadjuvant Chemoradiation Followed by Radical Hysterectomy in FIGO Stage IIIB Cervical Cancer: Feasibility, Complications, and Clinical Outcome (2009) (32)
- Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study. (2016) (32)
- Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications. (2018) (32)
- Perioperative outcomes of total laparoendoscopic single-site hysterectomy versus total robotic hysterectomy in endometrial cancer patients: a multicentre study. (2012) (31)
- Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? (2001) (31)
- Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. (2019) (31)
- First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma (2019) (31)
- Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. (2012) (30)
- Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status. (2020) (30)
- Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer (2018) (30)
- Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome. (2011) (30)
- One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer (2018) (30)
- Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations (2017) (30)
- Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials (2019) (30)
- Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study (2015) (30)
- Targeting the hallmarks of ovarian cancer: The big picture. (2016) (30)
- Perioperative Outcomes of Laparoendoscopic Single-Site Surgery (LESS) Versus Conventional Laparoscopy for Adnexal Disease: A Case—Control Study (2011) (29)
- Chemotherapy Resistance in Epithelial Ovarian Cancer: Mechanisms and Emerging Treatments. (2021) (29)
- Laparoscopy vs laparotomy for advanced ovarian cancer: a systematic review of the literature. (2019) (29)
- Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis. (2019) (29)
- Mini-laparoscopic versus robotic radical hysterectomy plus systematic pelvic lymphadenectomy in early cervical cancer patients. A multi-institutional study. (2015) (28)
- Laparoendoscopic single-site surgery for the treatment of benign adnexal diseases: a pilot study (2011) (28)
- Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study. (2015) (28)
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. (2021) (27)
- Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations (2014) (27)
- Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence (2019) (27)
- Laparoendoscopic single-site surgery (LESS) for treatment of benign adnexal disease: single-center experience over 3-years. (2012) (27)
- Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment (2020) (27)
- Laparoscopic myomectomy at 25 weeks of pregnancy: case report. (2010) (26)
- Characterization of the Skin Microbiota in Italian Stream Frogs (Rana italica) Infected and Uninfected by a Cutaneous Parasitic Disease (2015) (26)
- Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments. (2004) (26)
- Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center (2018) (25)
- Needleoscopic Conservative Staging of Borderline Ovarian Tumor. (2016) (25)
- Telelap Alf-X-Assisted Laparoscopy for Ovarian Cyst Enucleation: Report of the First 10 Cases. (2015) (25)
- SUCCOR cone study: conization before radical hysterectomy (2022) (25)
- European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery (2021) (25)
- Technological innovation and personalized surgical treatment for early-stage endometrial cancer patients: A prospective multicenter Italian experience to evaluate the novel percutaneous approach. (2019) (24)
- New Evidences of Mitochondrial DNA Heteroplasmy by Putative Paternal Leakage between the Rock Partridge (Alectoris graeca) and the Chukar Partridge (Alectoris chukar) (2017) (24)
- Which role for pre-treatment laparoscopic staging? (2007) (24)
- Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single‐center, real‐life experience (2020) (24)
- Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients (2016) (24)
- Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery (2019) (24)
- Comparison of minimally invasive surgery with laparotomic approach in the treatment of high risk endometrial cancer: A systematic review. (2019) (24)
- Laparoendoscopic Single-Site Surgery for the Treatment of Benign Adnexal Disease: A Prospective Trial (2010) (24)
- Bioaccumulation of organochlorine pesticides in frogs of the Rana esculenta complex in central Italy (2005) (23)
- Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study (2019) (23)
- Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes (2020) (23)
- Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study (2021) (22)
- Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) (2020) (22)
- Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis. (2020) (22)
- Sexual and Reproductive Outcomes in Early Stage Cervical Cancer Patients after Excisional Cone as a Fertility-sparing Surgery: An Italian Experience (2014) (22)
- Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): a multicentric experience. (2015) (22)
- Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease (2019) (22)
- Postoperative ileus after para-aortic lymphadenectomy: a prospective study. (2007) (22)
- The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget’s disease (2019) (21)
- Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery (2016) (21)
- Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies (2020) (21)
- Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: Does that make sense? A single-institution case-series. (2017) (21)
- Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery. (2006) (20)
- Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study. (2017) (20)
- Laparoendoscopic single-site hysterectomy: is it safe and feasible? (2014) (20)
- Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management? (2012) (19)
- Early postoperative bladder training in patients submitted to radical hysterectomy: is it still necessary? A randomized trial (2015) (19)
- Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study. (2011) (19)
- SUCCOR study. An international european cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, <4 cm) cervical cancer operated in 2013–2014 (2019) (19)
- Role of transvaginal ultrasound-guided biopsy in gynecology (2019) (19)
- Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer (2020) (19)
- Positron Emission Tomography–Laparoscopy Based Method in the Prediction of Complete Cytoreduction in Platinum-Sensitive Recurrent Ovarian Cancer (2015) (19)
- Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications (2003) (18)
- Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study. (2019) (18)
- Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach. (2020) (18)
- Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? (2020) (18)
- Robotic-Assisted Conservative Excision of Retrocervical-Rectal Deep Infiltrating Endometriosis: A Case Series. (2017) (18)
- Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature. (2019) (18)
- Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up. (2021) (17)
- Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer? (2015) (17)
- Minilaparoscopic radical hysterectomy for cervical cancer: multi-institutional experience in comparison with conventional laparoscopy. (2013) (17)
- Minilaparoscopic radical hysterectomy (mLPS-RH) vs laparoendoscopic single-site radical hysterectomy (LESS-RH) in early stage cervical cancer: a multicenter retrospective study. (2014) (17)
- Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis (2020) (17)
- Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience (2019) (17)
- The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience (2017) (17)
- Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series. (2017) (17)
- Laparoendoscopic Single-site Surgery for Fertility-sparing Staging of Border Line Ovarian Tumors: Initial Experience (2010) (17)
- Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers. (2016) (17)
- Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer (2011) (16)
- Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach. (2020) (16)
- Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome. (2018) (16)
- Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) (2019) (16)
- The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. (2012) (15)
- Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study. (2016) (15)
- Feasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: A multicentric Italian experience. (2019) (15)
- Narrow band imaging in borderline ovarian tumor. (2010) (15)
- Feasibility and surgical outcome in obese versus nonobese patients undergoing laparoendoscopic single-site hysterectomy: a multicenter case-control study. (2015) (15)
- Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer (2020) (15)
- Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study (2005) (14)
- The mammalian anti-α-smooth muscle actin monoclonal antibody recognizes an α-actin-like protein in planaria (Dugesia lugubris s.l.) (1992) (14)
- Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series. (2016) (14)
- A novel HIPEC technique using hybrid CO2 recirculation system: intra-abdominal diffusion test in a porcine model (2018) (14)
- Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer (2019) (14)
- Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue. (2000) (14)
- Short-term cadmium exposure induces stress responses in frog (Pelophylax bergeri) skin organ culture. (2015) (14)
- Droplet Digital PCR for Large Genomic Rearrangements detection: a promising strategy in tissue BRCA1 testing. (2020) (14)
- Reviewing vulvar Paget’s disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE (2019) (14)
- Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women (2011) (13)
- Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study. (2020) (13)
- Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology. (2014) (13)
- Characterization and immunocytochemical localization of actin and fibronectin in haemocytes of the musselMytilus galloprovincialis (1996) (13)
- Peritoneal HPV‐DNA test in cervical cancer (PIONEER study): A proof of concept (2020) (13)
- Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome. (1998) (13)
- Acid phosphatases in mammalian tissues. Evidence for the existence of a 57 kDa Zn(2+)-dependent acid phosphatase form. (1992) (13)
- Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique. (2016) (13)
- Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study. (2016) (12)
- Molecular characterization and expression of a heat-shock cognate 70 (Hsc70) and a heat-shock protein 70 (Hsp70) cDNAs in Rana (Pelophylax) lessonae embryos. (2010) (12)
- Importance of a specialized pathologist for the examination of frozen sections of adnexal masses (2007) (12)
- Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study (2022) (12)
- Role of surgery in gynaecological sarcomas (2019) (12)
- Hypotension Prediction Index with non-invasive continuous arterial pressure waveforms (ClearSight): clinical performance in Gynaecologic Oncologic Surgery (2021) (12)
- The role of sentinel node in early ovarian cancer: a systematic review of the literature. (2019) (12)
- Role of robotic surgery in ovarian malignancy. (2017) (11)
- Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety (2017) (11)
- Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) (2020) (11)
- Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer. (2018) (11)
- Oestrogen and progesterone receptors in ovarian carcinoma (1998) (11)
- 1st Evidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer (2017) (11)
- External hemipelvectomy as treatment for solitary coxofemoral metastasis from endometrial carcinoma: Case report and review of the literature (2012) (11)
- The Role of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis (2020) (10)
- Purification and subcellular localization of Zn-dependent acid p-nitrophenylphosphatase in frog liver and comparison with other vertebrates. (1990) (10)
- Pembrolizumab for advanced cervical cancer: safety and efficacy (2020) (10)
- Endometrial cancer arising in both horns of didelphys uterus in a Down's syndrome woman. (2006) (10)
- Narrow-band imaging in laparoscopic management of cervical carcinoma. (2011) (10)
- The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. (2021) (10)
- Fibronectin from the hemolymph of the marine bivalve Mytilus galloprovincialis. Purification, immunological characterization and immunocytochemical localization (1994) (10)
- ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience (2019) (10)
- Fertility preservation in patients with BRCA mutations or Lynch syndrome (2021) (10)
- Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer. (2018) (10)
- Surgery-related complications and long-term functional morbidity after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT morb) (2020) (10)
- Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) (2019) (9)
- External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response (2019) (9)
- Urologic surgery in gynecologic oncology: a large single-institution experience. (2014) (9)
- Molecular characterization and expression of a divergent alpha-tubulin in planarian Schmidtea polychroa. (2003) (9)
- Acid phosphatases in the frog (Rana esculenta) skeletal muscle. Purification and some properties of the low molecular weight enzyme. (1991) (9)
- Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control (2016) (9)
- Characterization and fine-structural localization of actin-and fibronectin-like proteins in planaria (Dugesia lugubris s.l.) (1992) (9)
- Laparoscopic vs percutaneous hysterectomy in obese patients: a prospective evaluation (2019) (9)
- Standardized training programmes for advanced laparoscopic gynaecological surgery (2013) (9)
- Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? (2015) (9)
- Role of Pegylated Liposomal Doxorubicin (PLD) in Epithelial Ovarian Cancer (2004) (9)
- Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study. (2020) (9)
- Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference? (2022) (9)
- Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT (2020) (9)
- Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer (2021) (8)
- Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options. (2016) (8)
- The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation (2022) (8)
- Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. (2005) (8)
- Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experience (2019) (8)
- Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience (2020) (8)
- Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study (2020) (8)
- Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival (2021) (8)
- Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review (2021) (8)
- [Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions]. (2011) (8)
- Advances in surgical management of cervical cancer. (2009) (8)
- Presumed early ovarian cancer with isolated tumor cells in para-aortic sentinel nodes (2019) (8)
- Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular Invasion (2018) (8)
- Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis. (2005) (8)
- NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer (2021) (7)
- Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? (2008) (7)
- Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset (2022) (7)
- Radiofrequency bipolar coagulation for radical hysterectomy: Technique, feasibility and complications (2002) (7)
- Secondary cytoreduction in ovarian cancer: who really benefits? (2018) (7)
- Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma. (2017) (7)
- The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma (2021) (7)
- Longitudinal study of Amphibiocystidium sp. infection in a natural population of the Italian stream frog (Rana italica) (2019) (7)
- Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery (2021) (7)
- Phase III SCORPION trial (ID number: NCT01461850) in epithelial ovarian cancer patients with high tumor load receiving PDS versus NACT: An interim analysis on peri-operative outcome (2015) (7)
- Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients (2022) (7)
- Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators (2021) (7)
- Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study (2019) (6)
- Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer. (2017) (6)
- Actin isoforms in amphioxus Branchiostoma lanceolatum (1998) (6)
- Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery (2011) (6)
- Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant. (2019) (6)
- Intraoperative ultrasound through laparoscopic probe in fertility‐sparing surgery for borderline ovarian tumor recurrence (2019) (6)
- CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset (2022) (6)
- 594 Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study (2020) (6)
- Narrow-band imaging in laparoscopic management of recurrent platinum sensitive ovarian cancer. (2013) (6)
- Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience (2022) (6)
- Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: A propensity-score matching analysis. (2021) (6)
- Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer (2019) (6)
- Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application (2022) (6)
- Total Microlaparoscopic Radical Hysterectomy in Early Cervical Cancer (2013) (6)
- The delayed effects of meteorological changes on the water frogs in Central Italy (2014) (6)
- Secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: are we missing something? (2019) (6)
- Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy (2020) (5)
- Risk factors for bloodstream infections in gynecological cancer (2020) (5)
- Management of ovarian masses in pregnancy: patient selection for interventional treatment (2020) (5)
- Introducing the New Surgical Robot HUGO™ RAS: System Description and Docking Settings for Gynecological Surgery (2022) (5)
- Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases. (2020) (5)
- Multiple isoform recovery (MIR)-PCR: a simple method for the isolation of related mRNA isoforms. (1998) (5)
- A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial (2021) (5)
- Small heat shock proteins in the amphibian Pelophylax bergeri: Cloning and characterization of Hsp27 and Hsp30 cDNAs and their expression analysis in ex vivo skin exposed to abiotic stresses. (2019) (5)
- Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach (2021) (5)
- Radical Surgery in Advanced Cervical Cancer Patients Receiving Bevacizumab-Containing Chemotherapy: A “Real Life Experience” (2018) (5)
- Obturator nerve regeneration using a genito-femoral graft placed only by fibrin sealant (Tisseel®). (2019) (5)
- Perspectives, Fears and Expectations of Patients with Gynaecological Cancers During the COVID-19 Pandemic: A Pan-European Study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (2020) (5)
- Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye (2020) (5)
- Intraoperative Ultrasound-Guided Excision of Cardiophrenic Lymph Nodes in an Advanced Ovarian Cancer Patient (2018) (5)
- Different Surgical Approaches for Early-Stage Ovarian Cancer Staging. A Large Monocentric Experience (2022) (5)
- Endometrial Stromal Sarcoma Arising from Endometriosis (2017) (5)
- Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series (2020) (5)
- Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine (2020) (5)
- BRCA testing delay during the COVID-19 pandemic: How to act? (2020) (5)
- Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation. (2013) (5)
- Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literature (2020) (5)
- New developments in rare vulvar and vaginal cancers (2021) (4)
- A laparoscopic adjusted model able to predict the risk of intraoperative capsule rupture in early stage ovarian cancer: Laparoscopic Ovarian Cancer Spillage Score (LOChneSS Study). (2022) (4)
- The safety of bevazicumab for the treatment of ovarian cancer (2018) (4)
- Feasibility and safety of two different surgical routes for the eradication of recto‐vaginal endometriosis with vaginal mucosa infiltration (Endo‐Vag‐r study) (2020) (4)
- Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer (2022) (4)
- PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients (2021) (4)
- Robotic versus laparoscopic surgery in gynecology: which should we use? (2016) (4)
- Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial) (2021) (4)
- Simplified anatomical nomenclature of lateral female pelvic spaces (2022) (4)
- Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection. (2018) (4)
- First evidence of heteroplasmy in Grey Partridge (Perdix perdix) (2020) (4)
- Percutaneous-Assisted versus Laparoscopic Hysterectomy: A Prospective Comparison (2020) (4)
- High-resolution melting analysis coupled with next-generation sequencing as a simple tool for the identification of a novel somatic BRCA2 variant: a case report (2018) (4)
- Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: a multi-institutional study. (2013) (4)
- Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer. (2016) (4)
- Acid phosphatase in planarians (Dugesia lugubris s.l.). Purification and partial characterization of the major enzyme form (1992) (4)
- Immunotherapy in cervical cancer: the advent of precision medicine (2020) (4)
- SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer (2022) (4)
- What is paracervical lymphadenectomy? (2021) (4)
- Expression of αSM actin in terrestrial ectothermic vertebrates (1995) (3)
- Purification and some properties of a Mg(2+)-activated acid phosphatase from rat testis. (1994) (3)
- Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital (2021) (3)
- Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient. (2006) (3)
- Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study (2021) (3)
- European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma (2021) (3)
- Cytoskeletal proteins and morphogenesis in planarians (2006) (3)
- Developmental stages of Amphibiocystidium sp., a parasite from the Italian stream frog (Rana italica). (2020) (3)
- Oregovomab: an investigational agent for the treatment of advanced ovarian cancer (2021) (3)
- Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer. (2021) (3)
- Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond (2021) (3)
- Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: A propensity match analysis. (2021) (3)
- Expression of an actin in protochordates and lower craniates defined by anti-alpha SM-1. (1996) (3)
- Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings (2021) (3)
- Can somatic BRCA2 status solve a case of olaparib monotherapy resistance? (2019) (3)
- Adult Granulosa Cell Tumor in Pregnancy: A New Case and a Review of the Literature (2021) (3)
- Robotic Pelvic Exenteration for Gynecologic Malignancies, Anatomic Landmarks, and Surgical Steps: A Systematic Review (2021) (3)
- Surgical Treatment of “Large Uterine Masses” in Pregnancy: A Single-Center Experience (2021) (3)
- Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance (2022) (3)
- Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing (2020) (3)
- Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. (2010) (3)
- Fighting against the challenge of treating patients with late-line ovarian cancer: are we there yet? (2019) (3)
- Prognostic Significance of Receptors for Epidermal Growth Factor, Estrogen, and Progesterone in Ovarian Cancer (1996) (3)
- 8 A multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic hysterectomy for the treatment of low-risk endometrial cancer: the ROMANHY trial (NCT:02762214) (2020) (2)
- Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO) (2022) (2)
- Update on new imaging technologies in sentinel node detection. (2020) (2)
- Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study. (2022) (2)
- BRCA tumor-testing in a tertiary referral center: Are we missing something or not? (2020) (2)
- Laparoendoscopic Single-Site Isobaric Hysterectomy in Endometrial Cancer (2013) (2)
- Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis (2021) (2)
- ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery—What We Know and Future Perspectives (2022) (2)
- Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience (2014) (2)
- Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team (2021) (2)
- Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients (2022) (2)
- Role of cytoreductive surgery in recurrent ovarian cancer (2010) (2)
- Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON. (2021) (2)
- Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes (2019) (2)
- Intraoperative ultrasound assistance during myomectomy in pregnant woman (2020) (2)
- 2022-RA-1057-ESGO Outcomes of gynaecological cancer surgery during the covid-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study (2022) (2)
- Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study (2022) (2)
- SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer (2022) (2)
- Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer (2023) (2)
- Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps (2022) (2)
- Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study (2021) (2)
- The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery. (2022) (2)
- Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis (2019) (2)
- Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase Inhibitors. (2022) (1)
- Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress. (2020) (1)
- Use of Laparoscopic and Laparotomic J-Plasma Handpiece in Gynecological Malignancies: Results From A Pilot Study in A Tertiary Care Center (2022) (1)
- BRCA status assessment in epithelial ovarian cancer and the challenge of tumor testing (2020) (1)
- ASO Author Reflections: Rectosigmoid Mesorectal Sparing Resection: A Feasible Technique and a Viable Option in Advanced Ovarian Cancer Surgery (2021) (1)
- Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers. (2013) (1)
- Ovarian cancer surgery and BRCA test: a nationwide Italian survey (2020) (1)
- Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study (2022) (1)
- Cytoskeletal protein expression in planarians (1993) (1)
- Actin expression in some Platyhelminthe species. (1994) (1)
- ASO Author Reflections: Minimally Invasive Secondary Cytoreductive Surgery for Ovarian Cancer Lymph Node Recurrence: Shaping Treatment with All Arrows in our Quiver (2022) (1)
- Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTISS retrospective multicenter study. (2022) (1)
- Re: "Diagnostic open laparoscopy in the management of advanced ovarian cancer". (2006) (1)
- 747 Ovarian cancer onset across different BRCA mutation type (2021) (1)
- Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer (2015) (1)
- Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer (2022) (1)
- 2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial (2022) (1)
- 960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients (2021) (1)
- Intraoperative ultrasound assistance for surgical removal of lost intrauterine device (2019) (1)
- 336 Is a vaginectomy enough or is a pelvic exenteration always required for surgical treatment of recurrent cervical cancer? (2020) (1)
- Cytochemical localisation of adenylate cyclase during nervous tissue induction in Bufu bufo embryos (1991) (1)
- P0563THE SHORT AND LONG-TERM EFFECTS OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY ON RENAL FUNCTION IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER (2020) (1)
- The modulation and spatial distribution of an anti-αSM-1 reactive actin during planarian wound repair (1994) (1)
- How to Evaluate Tumor Burden Before Therapeutic Decision (2017) (1)
- BRCA mutational status to personalize upfront management in high-grade serous advanced ovarian cancer: A multicenter study (2017) (1)
- Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation (2021) (1)
- Laparoscopic Adnexal Surgery (2014) (1)
- 27 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer (2020) (1)
- Evaluation of a novel classification of cervical adenocarcinoma to predict pelvic lymph node status in patients with early-stage cervical cancer (2019) (1)
- Current and future trials about HIPEC in ovarian cancer. (2023) (1)
- Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study (2023) (1)
- Diagnostic performance of ultrasound in assessing the extension of the disease in patients with suspicion of malignant ovarian tumor: correlation between ultrasound parameters and Fagotti’s score (2020) (1)
- BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score (2022) (1)
- Expression of alpha SM actin in terrestrial ectothermic vertebrates. (1995) (1)
- Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis. (2022) (1)
- Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer. (2017) (1)
- A common pattern of somatic mutations in t‐MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer (2022) (1)
- Risk based triage for complex surgery in ovarian cancer: ready for prime time (2021) (1)
- PRESENCE OF ALPHA -SMOOTH ACTIN IN PRIMITIVE BONY FISH SMOOTH MUSCLE (1996) (1)
- Reply to: Laparoscopy or minilaparotomy as minimally invasive surgical approach for uterine leiomyomas? An unsolved question (2006) (1)
- Comparison of quality of life after secondary cytoreductive surgery (SCS) ± HIPEC in recurrent ovarian cancer (2015) (1)
- Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer. (2022) (1)
- Morphogenesis of the frontal organ in Bufo bufo during development (1990) (1)
- Peritoneal Carcinomatosis From Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma. (2018) (1)
- Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer (2022) (1)
- MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. (2022) (1)
- Some criticism about postoperative pain after adnexal surgery performed by single-port versus standard laparoscopy. (2013) (1)
- Letter to the editorReply of the Authors (2011) (1)
- The Effectiveness of Psychological Therapy in Patients with Gynecological Cancer (2021) (1)
- 2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03) (2022) (1)
- The BRCA1 c.788G > T (NM_007294.4) variant in a high grade serous ovarian cancer (HGSOC) patient: foods for thought (2021) (1)
- Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study (2023) (1)
- RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers". (2011) (1)
- Laparoscopic diagnosis of asymptomatic megaureter. (2006) (1)
- SF009/#460 Minimally invasive secondary cytoreductive surgery for celiac and cardiophrenic isolated nodal recurrence of ovarian cancer (2021) (0)
- TOLERABILITY OF BEVACIZUMAB IN ELDERLY OVARIAN CANCER PATIENTS (2019) (0)
- 2022-RA-1214-ESGO Best option treatment in first line setting for low grade serous ovarian cancer:a case-control study (2022) (0)
- Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients (2022) (0)
- ANTIBODY–DRUG CONJUGATE ANETUMAB RAVTANSINE IN COMBINATION WITH PEGYLATED- LIPOSOMAL DOXORUBICIN IN PLATINUM-RESISTANT OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER (2020) (0)
- Cloning and sequencing of an actin cDNA from planarian Dugesia tigrina (1996) (0)
- 242 PARP-inhibitors beyond progression: a new way to manage oligometastatic ovarian cancer recurrence (2021) (0)
- [Biological factors with prognostic significance in ovarian cancer]. (2001) (0)
- 827 How to do retroperitoneal en bloc posterior pelvic exenteration in advanced ovarian cancer: Hudson-Dellepiane procedure in 10 steps (2021) (0)
- Role of substage and histologic subtype in stage I epithelial ovarian cancer survival: a multicenter retrospective observational study (2022) (0)
- 343 External validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer undergoing primary surgery (2020) (0)
- 534 BRCA status and platinum-sensitivity in advanced ovarian cancer: a pathological evaluation after neoadiuvant chemotherapy (2021) (0)
- Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE) (2022) (0)
- 2022-RA-1218-ESGO Physiologically relevant treatment models to investigate epigenetic mechanisms driving platinum resistance in ovarian high grade serous carcinoma (2022) (0)
- Minimally invasive interval debulking surgery in AEOC: Preliminary results from the MISSION trial (2015) (0)
- 2022-LBA-746-ESGO Implementation of a comprehensive cancer genome profiling programme into clinical practice: an italian experience in a referral centre for gynecological cancers (2022) (0)
- 2022-RA-817-ESGO Comparison of surgeon’s intraoperative assessment of residual tumor and postoperative findings on computed tomography in patients with advanced stage epithelial ovarian, tubal or peritoneal cancer – a retrospective cohort study (2022) (0)
- What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study (2022) (0)
- 2022-VA-996-ESGO Ten steps robotic intensive staging for early-stage ovarian cancer (2022) (0)
- Consensus on the Gemelli terminology of surgical anatomy for radical hysterectomy (2023) (0)
- 2022-RA-1341-ESGO Minimally invasive versus open pelvic exenterationin gynecological malignancies: a propensity-matched survival analysis (2022) (0)
- Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era-Is it time for a new paradigm shift? A systematic review and meta-analysis. (2023) (0)
- 2022-RA-634-ESGO Trabectedin plus pegylated liposomaldoxorubicin in patients who experienced disease progression after PARPi maintenance: a real life case-control study (2022) (0)
- 64 Can chemotherapy change tumor BRCA status and affect susceptibility to treatment? (2020) (0)
- 8 Multiple isoform recovery (MIR)-PCR: a simple method for the isolation of related mRNA (1998) (0)
- 2022-RA-624-ESGO OVA-LEAK: prognostic score for colo-rectal anastomotic leakage in patients undergoing ovariancancer surgery (2022) (0)
- Re: "External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score". (2009) (0)
- Laparoendoscopic Single-Site (LESS) Hysterectomy (2018) (0)
- Editorial Board (2018) (0)
- 2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22 (2022) (0)
- High resolution melting profiles (HRMPs) obtained by magnetic induction cycler (MIC) have been used to monitor the BRCA2 status highlighted by next generation tumor sequencing (NGTS): a combined approach in a diagnostic environment (2020) (0)
- P13 Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node micro-metastasis in early-stage cervical cancer (2019) (0)
- 1048 TRansInguinal pelvic lymphadenectomy in vulvar cancer patients (TRIPLE STUDY): a single-institution, prospective, pilot study (2021) (0)
- M487 PLATELET GEL AND VULVAR CARCINOMA: A PILOT STUDY (2012) (0)
- The Psychological Impact on 472 Gynecological Cancer Patients: First Diagnosis vs. Disease Recurrence (2021) (0)
- ASO Visual Abstract: Visual Peritoneal Evaluation of Residual Disease After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients—The VIPER Study (2023) (0)
- Potential Role of the Cutaneous Bacterial Community in Amphibian Innate Defences Against Pathogens (2011) (0)
- 1071 The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar squamous cell carcinoma (2021) (0)
- Isolated tumour cells in a sentinel lymph node of apparent early-stage ovarian cancer: Ultrastaging of all other 27 lymph nodes (2022) (0)
- The ratio between type 1 and type 2 tumor-associated macrophages predicts prognosis in patients with locally advanced cervical cancer receiving chemoradiation (2015) (0)
- Laparoscopia e cancro ovarico (2008) (0)
- 293 Quality of training in cervical cancer surgery: a survey from the European network of young gynaecologic oncologists (ENYGO) (2021) (0)
- Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review (2022) (0)
- 267 Retrospective study evaluating the role of transvaginal ultrasound guided biopsy in gynecological cancer patients (2019) (0)
- Cervical cancer in Tosamaganga Hospital, Tanzania: difficulties and challenges in a low resource country setting (2019) (0)
- OP022/#597 Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: a propensity-score matching analysis (2021) (0)
- OC12.04: A new advanced tool in gynecological surgery: the intraoperative ultrasound examination (2019) (0)
- LAPAROSCOPIC SALVAGE LYMPHADENECTOMY IN ISOLATED LYMPH NODE RECURRENT OVARIAN CANCER PATIENTS (2021) (0)
- Reply of the Authors: Patient's fertility desire should be taken into consideration in the surgical treatment algorithm of infiltrating endometriosis (2010) (0)
- P126 Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: systematic review and metanalysis (2019) (0)
- HSP70 upregulation in nasal mucosa of symptomatic children with allergic rhinitis and potential risk of asthma development (2022) (0)
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review (2022) (0)
- Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers. (2022) (0)
- Visual Peritoneal Evaluation of Residual Disease After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients: The VIPER Study (2023) (0)
- Chemoradiation versus neoadjuvant chemoradiation followed by radical surgery for FIGO stage III cervical cancer: Analysis of complications and 3-year survival (2015) (0)
- Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers. (2021) (0)
- Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer (2020) (0)
- Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections (2022) (0)
- Indications for Laparoscopic Assessment of Cytoreduction (2018) (0)
- 462 Predictive radiogenomic model based on ovarian ultrasound images to detect germline brca 1-2 status (probe study) a radiogenomic model on us images (2020) (0)
- Endometriosi e cancro (2005) (0)
- O269 UPDATED STRATIFIED PLAN FOR VULVAR CANCER MANAGEMENT (2012) (0)
- ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience. (2019) (0)
- PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study (2023) (0)
- 633 Health care associated infection in gynecologic oncology: clinical and economic impact. Large retrospective single-institution study (2021) (0)
- Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI) (2020) (0)
- 2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis (2022) (0)
- 2022-RA-1580-ESGO Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (2022) (0)
- Laparoscopic selection for surgery in epithelial ovarian cancer. A short review. (2023) (0)
- BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation (2022) (0)
- O116 LAPAROENDOSCOPIC SINGLE SITE SURGERY (LESS) FOR THE TREATMENT OF BENIGN ADNEXAL DISEASE: A SINGLE CENTER EXPERIENCE OVER A THREE‐YEAR PERIOD (2012) (0)
- Nlr & Brca Mutational Status In Patients With High Grade Serous Advanced Ovarian Cancer: A Large Population Study (2021) (0)
- EP1301 Minimally-invasive cytoreduction in recurrent endometrial cancer: laparoscopic and uniportal video-assisted thoracoscopic surgery (VATS) combined approach (2019) (0)
- Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing (2020) (0)
- 2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients (2022) (0)
- AIOM recommendations on the use of cytoreductive surgery and HIPEC in primary and secondary peritoneal tumors (2021) (0)
- Scientific Plenary IV: The Farr Nezhat Surgical Innovation Session (2015) (0)
- 2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer? (2022) (0)
- SUN-PO119: Impact of Nutritional Support and Counseling During Chemotherapy on the Quality of Life of Ovarian Cancer Patients. Preliminary Results from a Prospective Study (2019) (0)
- OC10.02: *Diagnostic performance of ultrasound in assessing the extension of disease in patients with advanced ovarian cancer: a prospective study (2021) (0)
- Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases (2023) (0)
- The delayed effects of meteorological changes on the water frogs in Central Italy (2014) (0)
- EP918 Transvaginal/transabdominal sonography for histological diagnosis in advanced ovarian cancer patients: a single institution prospective study (2019) (0)
- Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes (2022) (0)
- EP1227 Nutritional interventions to improve clinical outcomes in ovarian cancer: a systematic review of randomized controlled trials (2019) (0)
- SENTINEL NODE IN OVARIAN CANCER: A CHALLENGE TO WIN. (2019) (0)
- 2022-RA-1356-ESGO Epithelial ovarian cancer and brain metastases: survival analysis according to the BRCA status (2022) (0)
- *Diagnostic performance of ultrasound in assessing the extension of disease in patients with advanced ovarian cancer: a prospective study (2021) (0)
- Reply (2020) (0)
- EP34.08: Role of transvaginal‐guided biopsy in gynecology: a retrospective study (2019) (0)
- 1088 Minimally-invasive pelvic exenteration: a survival analysis (2021) (0)
- Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient (2006) (0)
- 2022-RA-1456-ESGO Ovarian cancer metastases in the liver area: a retrospective analysis of surgical, intraoperative and postoperative outcomes according to a standardize anatomo-surgical classification (2022) (0)
- 42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation (2023) (0)
- High-resolution melting analysis coupled with next-generation sequencing as a simple tool for the identification of a novel somatic BRCA2 variant: a case report (2018) (0)
- Laparo Endoscopic Single Site Surgery (L.E.S.S.) in the Management of Ovarian Benign Disease (2009) (0)
- P114 Guidelines and selection criteria for lymphadenectomy in recurrent ovarian cancer patients (2019) (0)
- Peri-operative ovarian cancer guidelines: introduction, skin antisepsis, patient positioning, including retractors use and nutritional management (2022) (0)
- The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer (2022) (0)
- 2022-RA-1367-ESGO Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study (2022) (0)
- Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study (2007) (0)
- Long-term survival of early stage I epithelial ovarian cancer: A multicenter retrospective observational study (321) (2022) (0)
- W110 THE SONOGRAPHIC PREDICTION OF INVASIVE CARCINOMA IN UNILOCULAR‐SOLID OVARIAN CYSTS IN PREMENOPAUSAL PATIENTS: A PILOT STUDY (2012) (0)
- 2022-LBA-677-ESGO Distribution and prognostic role of BRCA status in elderly ovarian cancer patients (2022) (0)
- NUTRITIONAL MANAGEMENT OF PANCREATIC FISTULA POST SPLENECTOMY DURING CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER (2021) (0)
- PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER PATIENTS : A CASE-CONTROL STUDY ON SURVIVAL IN PATIENTS WITH A TWO YEARS FOLLOW-UP (2012) (0)
- EPV218/#551 Development of a nomogram to predict the feasibility of minimally invasive interval debulking surgery in patients with advanced ovarian cancer: a large monocentric cohort study (2021) (0)
- EP459 Clinical management of ovarian masses in pregnancy (2019) (0)
- Subject Index Vol. 65, 2003 (2003) (0)
- Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer (2022) (0)
- Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial. (2023) (0)
- ASO Visual Abstract: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A large Single-Center Experience (2022) (0)
- 991 Fertility sparing surgery in cervical cancer patients outside controlled trials – a multicenter retrospective cohort trial (CEEGOG Cx-03; ENGOT-CX14) (2021) (0)
- Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis (2019) (0)
- Minimally-invasive cytoreduction in recurrent endometrial cancer: laparoscopic and uniportal video-assisted thoracoscopic surgery combined approach (2019) (0)
- Subject Index Vol. 75, 2008 (2008) (0)
- RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery (2016) (0)
- 44 Minimally invasive surgical staging for early stage ovarian cancer: a long term follow up (2020) (0)
- Oncological outcomes of patients with cervical cancer after fertility-sparing treatment – fertiss retrospective multicenter trial (2022) (0)
- EP381 The role of diagnostic laparoscopic in locally advanced cervical cancer staging in the bevacizumab era (2019) (0)
- 821 Different surgical approaches for early-stage ovarian cancer staging: a large monocentric experience (2021) (0)
- EP1283 Preliminary experience in the use of J-Plasma device in gynecological malignancies (2019) (0)
- PREOPERATIVE NUTRITIONAL STATUS ASSESSED BY CT SCAN IN PATIENTS WITH NEWLY-DIAGNOSED ADVANCED OVARIAN CANCER: A PROSPECTIVE STUDY (2021) (0)
- HSP70 upregulation in nasal mucosa of symptomatic children with allergic rhinitis and potential risk of asthma development (2022) (0)
- 2022-RA-1515-ESGO Impact of surgical staging on survival of low grade endometrioid ovarian cancer apparently confined to the ovary (2022) (0)
- Steroid hormone receptors and ovarian cancer (1998) (0)
- 2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery (2022) (0)
- OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery. (2022) (0)
- 5P Physiologically relevant treatment models to investigate epigenetic mechanisms driving platinum resistance in ovarian high grade serous carcinoma (2023) (0)
- MON-P278: May High Complexity Surgery, in Gynecological Oncology Patients, Worsen Nutritional Status During Hospital Stay? A Cross-Sectional Study in an Italian University Hospital (2017) (0)
- COMPARATIVE STUDY OF LAPARASCOPY SCORING AND LAPARATOMY STAGING IN ADVANCE OVARIAN CANCER (2021) (0)
- Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative (2022) (0)
- 1114 Laparoscopic salvage lymphadenectomy in isolated lymph node recurrent ovarian cancer patients (2021) (0)
- P121 Surgical secondary cytoreduction in recurrent ovarian cancer patients with liver metastasis (2019) (0)
- 332 Indocyanine green to assess vascularity of ileal conduit anastomosis during pelvic exenteration for recurrent/persistent gynecological cancer (2021) (0)
- Low-grade serous ovarian cancer in pregnancy (2022) (0)
- Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study (2022) (0)
- 2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy (2022) (0)
- 529 Minimally invasive secondary cytoreductive surgery for celiac and cardiophrenic isolated nodal recurrence of ovarian cancer (2021) (0)
- Reply to “Let’s Think Twice Before Abandoning Fibrillar Oxidized Regenerated Cellulose” (2011) (0)
- P141 Let’s think twice before abandoning secondary cytoreductive surgery in recurrent ovarian cancer (2019) (0)
- 2022-RA-1414-ESGO Pattern of recurrence and CA125 monitoring in BRCA wild-typerecurrent ovarian cancer patients under maintenance with Niraparib (2022) (0)
- Contents Vol. 65, 2003 (2003) (0)
- Response to: Should we or should we not? Risk reduction bilateral salpingectomy for BRCA mutation carriers (2021) (0)
- Contents Vol. 75, 2008 (2008) (0)
- 2022-RA-1375-ESGO Minimally invasive vs. open interval debulking surgery in advanced ovarian cancer patients: pattern of recurrence and oncological outcome in a propensity matched population (2022) (0)
- Impact of neoadjuvant chemotherapy on fitness for surgery in high-risk patients with advanced ovarian cancer (566) (2022) (0)
- EP802 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer (2019) (0)
- O016/#739 Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study (2022) (0)
- 373 Protective role of conization before radical hysterectomy in early-stage cervical cancer: a propensity-score matching study (2020) (0)
- Laparoscopic intra-operative ultrasound-guided bilateral salpingo-oophorectomy in a BRCA2 mutated patient (2019) (0)
- Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer (2023) (0)
- Retrospective study evaluating the role of Transvaginal Ultrasound Guided Biopsy in Gynecological Cancer Patients (2019) (0)
- 2022-RA-853-ESGO Analysis of the gender distribution among the invited speakers at European society of gynaecological oncology (ESGO) biannual congresses 2017, 2019, and 2021 (2022) (0)
- THE LYMPHATIC DRAINAGE OF THE UTERINE CERVIX IN 1 ADULT FRESH CADAVERS : 2 ANATOMY AND SURGICAL IMPLICATIONS 3 4 (2017) (0)
- Original Research Report Preoperative chemoradiotherapy in locally advanced cervical cancer: Long-term outcome and complications (2005) (0)
- VP66.29: Clinical management of ovarian masses in pregnancy (2020) (0)
- OP07.13: Prospective study evaluating the role of ultrasound‐guided biopsy as a useful tool in patients with suspected advanced ovarian cancer (2022) (0)
- Similar Molecular Pattern in Therapy Related Acute Myeloid Leukemia in Patients Treated with Purp Inhibitors for Metastatic Ovarian Cancer (2020) (0)
- O546 CYTOREDUCTIVE SURGERY PLUS HIPEC IN PLATINUM‐SENSITIVE RECURRENT OVARIAN CANCER PATIENTS: A CASE‐CONTROL STUDY ON SURVIVAL IN PATIENTS WITH A TWO YEARS FOLLOW‐UP (2012) (0)
- REPLY: SCORPION study: is it time to call primary debulking surgery superior? (2020) (0)
- Ovarian cancer treatment is evolving: more choices, more chances (2020) (0)
- ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer—A Multicenter Study (2018) (0)
- Role of HIPEC therapy in advanced ovarian cancer (2015) (0)
- OC14.04: Role of intraoperative ultrasound to extend minimally invasive surgery for treatment of recurrent gynecological cancer (2017) (0)
- P22.03: Ultrasound and color power Doppler examination in the detection of metastatic omentum: a prospective study (2006) (0)
- O538 A RANDOMIZED STUDY COMPARING THE USE OF THE LIGACLIP WITH ENSEAL TO PREVENT LYMPHOCELE DURING LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR GYNECOLOGIC CANCER (2012) (0)
- Minimally invasive versus open pelvic exenteration in gynecological malignancies: a propensity-matched survival analysis (2023) (0)
- EP840 Hipec at interval debulking surgery in advanced stage ovarian cancer patients: impact of the OVHIPEC-1 trial in real life experience of a tertiary referral centre (2019) (0)
- Techniques for Single-Port Gynecologic Oncology (2014) (0)
- Tips and tricks for ileostomy closure after diverting ileostomy for gynecological cancer surgery (2023) (0)
- ASO Author Reflections: Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (2020) (0)
- Retroperitoneal schwannoma during pregnancy: case-report and practice-based overview (2023) (0)
- VP66.26: Diagnostic performance of ultrasound in assessing the abdominal spread of advanced ovarian cancer and correlation to Fagotti score: a prospective study (2020) (0)
- Chapter-31 Laparoscopic management of cervical cancer (2016) (0)
- O724 A PROSPECTIVE MULTI‐CENTRIC TRIAL (PROTOCOL ID: OLYMPIA – MITO 13) TO VALIDATE THE RELIABILITY OF A LAPAROSCOPIC SCORE IN AOC PATIENTS TO ASSESS INTRAPERITONEAL DIFFUSION OF THE DISEASE (2012) (0)
- The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study (2022) (0)
- 132P Genomic profiling of primary and recurrent ovarian cancers: A retrospective single-center experience (2022) (0)
- 72 Can intraoperative visual examination of diaphragmatic peritoneum be a reliable tool to modulate the extent of interval debulking surgery in advanced ovarian cancer? (2020) (0)
- ASO Author Reflections: Laparoscopic Ovarian Transposition for Locally Advanced Cervical Cancer—Tailoring the Treatment with the Standardization of a Surgical Procedure (2022) (0)
- Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy. (2023) (0)
- 2022-RA-1441-ESGO Epithelial ovarian cancers during pregnancy: the results of a large retrospective study from the INCIP network (2022) (0)
- Abstract 4144: Role of CTGF in hyperthermia resistance in ovarian and uterine cancers (2017) (0)
- Intraoperative Endoscopic Ultrasound Guided Surgical Treatment of Herlyn-Werner-Wunderlich Syndrome. Case Report and a Systematic Literature Review (2020) (0)
- The mammalian anti-alpha-smooth muscle actin monoclonal antibody recognizes an alpha-actin-like protein in planaria (Dugesia lugubris s.l.). (1992) (0)
- Transvaginal ultrasound-guided biopsy in patients with suspicious primary advanced tubo-ovarian carcinoma (2022) (0)
- OP03.09: The sonographic prediction of invasive carcinoma in unilocular‐solid ovarian cysts in premenopausal patients: a pilot study (2012) (0)
- IGCS 20 _ 1501 460 DIFFUSE LARGE B-CELL LYMPHOMA OF THE OVARY : A SERIES OF FOUR CASES 1 K (2020) (0)
- Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations (2021) (0)
- 752P PARP-inhibitors beyond progression: A new way to manage oligometastatic ovarian cancer recurrence (2021) (0)
- Correction to: BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study (2018) (0)
- Healthcare associated infections in gynecologic oncology: clinical and economic impact (2022) (0)
- 39 Development of a nomogram to predict interval debulking surgery feasibility when primary cytoreduction is not an option (2020) (0)
- Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors (2023) (0)
- 2022-RA-685-ESGO What is beyond brca mutational status in high grade serous ovarian cancer? The role of hormone receptors expression (2022) (0)
- 1080 Update of the GroSNaPET study: on the way to overcome sentinel node limits in vulvar cancer (2021) (0)
- 2022-RA-1271-ESGO Ultrasound guided biopsy, a useful tool in the management of primary advanced tuboovarian carcinoma (2022) (0)
- EP856 Optimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: a case-control survival analysis (2019) (0)
- CAN INTRAOPERATIVE VISUAL EXAMINATION OF DIAPHRAGMATIC PERITONEUM BE A RELIABLE TOOL TO MODULATE THE EXTENT OF INTERVAL DEBULKING (2020) (0)
- How should randomized controlled trials in epithelial ovarian cancer be interpreted? (2022) (0)
- Distribution and characterization of actin and fibronectin-like proteins in planarians (1990) (0)
- Ovarian cancer metastases in the liver area: proposal of a standardized anatomo-surgical classification (2021) (0)
- 331 Preoperative nutritional status assessed by ct scan in patients with newly-diagnosed advanced ovarian cancer: a prospective study (2019) (0)
- EP1224 Predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience (2019) (0)
- SF021/#830 Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in brca1 mutated patient (2021) (0)
- Role of PDZ binding kinase (PBK) associated to guanylate binding protein 1 (GBP1) for drug resistance in ovarian cancer (2015) (0)
- EP704 Is SOFA score reliable in a gynecologic oncology setting or is something missing? A retrospective study on predictors and risk factors for bloodstream infections (2019) (0)
- ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer (2018) (0)
- Late isolated subcutaneous recurrence in an endometrial cancer patient submitted to panniculectomy (2010) (0)
- An Integrated Clinico-Radiogenomic Screening Program for the Identification of BRCA 1/2 Carriers: A Cost-Effectiveness Analysis(e-PROBE Study) (2022) (0)
- 848 Indocyanine green to assess vascularity of Bricker ileal conduit anastomosis during pelvic exenteration for recurrent cervical cancer (2021) (0)
- BRCA testing delay during the COVID-19 pandemic: How to act? (2020) (0)
- 377 Sentinel lymph node detection in endometrial cancer: laparoscopic versus robotic approach (2020) (0)
- 330 Tolerability of bevacizumab in elderly ovarian cancer patients (Turbo Study): a case-control study of a real-life experience (2019) (0)
- Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer (2023) (0)
- A commentary on the discrepancy between blood and tumour BRCA testing: An open question (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anna Fagotti?
Anna Fagotti is affiliated with the following schools:
